98%
921
2 minutes
20
HELLP syndrome, defined by hemolysis, elevated liver enzymes, and low platelets, is a life-threatening complication of preeclampsia that rarely coincides with acute pancreatitis during pregnancy. This combination poses profound risks for both mother and fetus. We describe a 29-year-old woman at 27 weeks of gestation who presented with severe abdominal pain, vomiting, and a history of hypertension. Laboratory evaluation revealed anemia, thrombocytopenia, elevated liver enzymes, renal dysfunction, and high amylase and lipase, confirming the diagnosis of HELLP syndrome associated with acute pancreatitis. Intensive care management included hemodynamic support, electrolyte correction, blood product transfusion, antihypertensive therapy, and an emergency cesarean section. Both maternal and neonatal outcomes were favorable. This case underscores the importance of early multidisciplinary intervention and comprehensive diagnostic evaluation when HELLP syndrome presents with atypical features such as pancreatitis. Prompt recognition and coordinated management are crucial to optimizing maternal and fetal outcomes in these rare and serious presentations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12381508 | PMC |
http://dx.doi.org/10.7759/cureus.88868 | DOI Listing |
Medicine (Baltimore)
August 2025
Department of Anaesthesiology, West China Second Hospital, Sichuan University, Chengdu, China.
Rationale: Subcapsular liver hematoma (SLH) during pregnancy is a rare but potentially life-threatening complication, often associated with hypertensive disorders such as preeclampsia and hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome.
Patient Concerns: We report the case of a 37-year-old primipara who presented at 39 weeks of gestation with severe preeclampsia (blood pressure, 166/106 mm Hg; proteinuria, 2+). Notably, her prenatal course was marked by normal blood pressure and 3 negative urine protein tests.
Open Heart
September 2025
The Alan Turing Institute, London, England, UK
Objective: Sex differences play a critical role in the presentation, progression and treatment outcomes of cardiac diseases. However, historical male predominance in clinical studies has led to disparities in evidence supporting care for both sexes. Clinical guidelines are essential for cardiovascular care, shaping practice and influencing patient outcomes.
View Article and Find Full Text PDFBJOG
August 2025
Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada.
Objective: To examine whether the associations between pre-pregnancy risk factors and severe preeclampsia/eclampsia (SPE) and/or HELLP syndrome differ between singleton and twin pregnancies.
Design: A population-based retrospective cohort study.
Setting: British Columbia (BC), Canada.
Cureus
July 2025
Critical Care Medicine, Hamad Medical Corporation, Doha, QAT.
HELLP syndrome, defined by hemolysis, elevated liver enzymes, and low platelets, is a life-threatening complication of preeclampsia that rarely coincides with acute pancreatitis during pregnancy. This combination poses profound risks for both mother and fetus. We describe a 29-year-old woman at 27 weeks of gestation who presented with severe abdominal pain, vomiting, and a history of hypertension.
View Article and Find Full Text PDFSci Rep
August 2025
Research Centre, Fundación Cardiovascular de Colombia - (FCV), Centro Internacional de Especialistas, Valle de Menzuly Km 7, Piedecuesta, Santander Bucaramanga, Colombia.
Extra-large HDL molecules (average diameter 14.3 nm) were inversely associated with preeclampsia. Additionally, extremely (particle diameters from 75 nm upwards) and very large (average diameter 64 nm) VLDL metabolites were associated with an increased the risk of preeclampsia.
View Article and Find Full Text PDF